Putting Insulin Glargine and Malignancies into Perspective

被引：10

作者：

Ehninger, Gerhard ^{[1
]}

Schmidt, Alexander H. ^{[1
]}

机构：

[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, D-01307 Dresden, Germany

来源：

ONCOLOGIST | 2009年 / 14卷 / 12期

关键词：

Insulin; Malignancy; Glargine; Colon; Pancreas; Breast; DIABETES-MELLITUS; CANCER; METAANALYSIS; RISK; MORTALITY; ANALOGS; COHORT;

D O I：

10.1634/theoncologist.2009-0206

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1169 / 1174

页数：6

共 21 条

[1] Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay [J].

Agin, A. ;

Jeandidier, N. ;

Gasser, F. ;

Grucker, D. ;

Sapin, R. .

DIABETES & METABOLISM, 2007, 33 (03) :205-212

[2] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].

Bowker, SL ;

Majumdar, SR ;

Veugelers, P ;

Johnson, JA .

DIABETES CARE, 2006, 29 (02) :254-258

[3] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].

Calle, EE ;

Rodriguez, C ;

Walker-Thurmond, K ;

Thun, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638

[4] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes [J].

Currie, C. J. ;

Poole, C. D. ;

Gale, E. A. M. .

DIABETOLOGIA, 2009, 52 (09) :1766-1777

[5] Proliferation of Colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine [J].

Erbel, Saskia ;

Reers, Christina ;

Eckstein, Volker W. ;

Kleeff, Joerg ;

Buechler, Markus W. ;

Nawroth, Peter P. ;

Ritzel, Robert A. .

DIABETES CARE, 2008, 31 (06) :1105-1111

[6]

GRILL M, 2009, SPIEGEL, V104, P104

[7] Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study [J].

Hemkens, L. G. ;

Grouven, U. ;

Bender, R. ;

Guenster, C. ;

Gutschmidt, S. ;

Selke, G. W. ;

Sawicki, P. T. .

DIABETOLOGIA, 2009, 52 (09) :1732-1744

[8] Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus [J].

Horvath, K. ;

Jeitler, K. ;

Berghold, A. ;

Ebrahim, S. H. ;

Gratzer, T. W. ;

Plank, J. ;

Kaiser, T. ;

Pieber, T. R. ;

Siebenhofer, A. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (02)

[9] Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies [J].

Huxley, R ;

Ansary-Moghaddam, A ;

de González, AB ;

Barzi, F ;

Woodward, M .

BRITISH JOURNAL OF CANCER, 2005, 92 (11) :2076-2083

[10]

*I QUAL EFF HLTH C, 2009, ABSCHL LANGW INS BEH, V2

← 1 2 3 →